Edesa Biotech Statistics

Total Valuation

Edesa Biotech has a market cap or net worth of $6.75 million. The enterprise value is $5.14 million.

Market Cap	6.75M
Enterprise Value	5.14M

Important Dates

The next estimated earnings date is Friday, December 13, 2024, after market close.

Earnings Date	Dec 13, 2024
Ex-Dividend Date	n/a

Share Statistics

Edesa Biotech has 3.25 million shares outstanding. The number of shares has increased by 17.51% in one year.

Current Share Class	3.25M
Shares Outstanding	3.25M
Shares Change (YoY)	+17.51%
Shares Change (QoQ)	+0.91%
Owned by Insiders (%)	17.88%
Owned by Institutions (%)	4.97%
Float	2.52M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	2.49
P/TBV Ratio	9.36
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.29, with a Debt / Equity ratio of 0.01.

Current Ratio	1.29
Quick Ratio	1.10
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -129.29% and return on invested capital (ROIC) is -96.35%.

Return on Equity (ROE)	-129.29%
Return on Assets (ROA)	-71.52%
Return on Capital (ROIC)	-96.35%
Revenue Per Employee	n/a
Profits Per Employee	-$433,021
Employee Count	16
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, Edesa Biotech has paid $800 in taxes.

Income Tax	800
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -30.89% in the last 52 weeks. The beta is 0.84, so Edesa Biotech's price volatility has been lower than the market average.

Beta (5Y)	0.84
52-Week Price Change	-30.89%
50-Day Moving Average	3.58
200-Day Moving Average	4.31
Relative Strength Index (RSI)	23.02
Average Volume (20 Days)	49,553

Short Selling Information

The latest short interest is 16,551, so 0.51% of the outstanding shares have been sold short.

Short Interest	16,551
Short Previous Month	19,836
Short % of Shares Out	0.51%
Short % of Float	0.66%
Short Ratio (days to cover)	1.08

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-8.38M
Pretax Income	-6.93M
Net Income	-6.93M
EBITDA	-8.27M
EBIT	-8.38M
Earnings Per Share (EPS)	-$2.20

Full Income Statement

Balance Sheet

The company has $2.04 million in cash and $38,817 in debt, giving a net cash position of $2.00 million or $0.62 per share.

Cash & Cash Equivalents	2.04M
Total Debt	38,817
Net Cash	2.00M
Net Cash Per Share	$0.62
Equity (Book Value)	2.87M
Book Value Per Share	0.88
Working Capital	686,007

Full Balance Sheet

Cash Flow

Operating Cash Flow	-5.39M
Capital Expenditures	n/a
Free Cash Flow	-5.39M
FCF Per Share	-$1.66

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Edesa Biotech does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-17.51%
Shareholder Yield	-17.51%
Earnings Yield	-96.98%
FCF Yield	-75.46%

Analyst Forecast

The average price target for Edesa Biotech is $21.00, which is 909.62% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$21.00
Price Target Difference	909.62%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on October 11, 2023. It was a reverse split with a ratio of 0.1428571:1.

Last Split Date	Oct 11, 2023
Split Type	Reverse
Split Ratio	0.1428571:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	1